FDA awards two grants for natural history studies in rare diseases

FDA awards two grants for natural history studies in rare diseases The U.S. Food and Drug Administration today announced it has awarded two new research grants for natural history studies in rare diseases. The FDA is providing over $4.1 million over the next four years to fund these studies. Information from natural history studies can facilitate design of efficient clinical trials to test future treatments. Natural history studies closely look at how specific diseases progress over time. The natural history of a disease is the course a disease takes from its onset, through the presymptomatic and clinical stages, to a ...

Read More